Growth Regulatory Pathways in Myeloma: Evidence for Autocrine Oncostatin M Expression

Journal of Immunology

Volumn 157, Issue 7, 1996, Pages 3081-3088

  Westendorf, Jennifer J ^a,b   Jelinek, Diane F ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 130; IL6ST PROTEIN, HUMAN; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NERVE PROTEIN; ONCOSTATIN M; OSM PROTEIN, HUMAN; PEPTIDE; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PATHOLOGY; PEPTIDE SYNTHESIS;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BASE SEQUENCE; CELL DIVISION; CILIARY NEUROTROPHIC FACTOR; CYTOKINE RECEPTOR GP130; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; ONCOSTATIN M; PEPTIDE BIOSYNTHESIS; PEPTIDES; TUMOR CELLS, CULTURED;

EID: 0030266773     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, A. Kuramoto, and T. Kishimoto. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332:83.
2. Van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8:253.
3. Hata, H., H. Xiao, M. T. Petrucci, J. Woodliff, R. Chang, and J. Epstein. 1993. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 81:3357.
4. Westendorf, J. J., G. J. Ahmann, R. J. Armitage, M. K. Spriggs, J. A. Lust, P. R. Greipp, J. A. Katzmann, and D. F. Jelinek. 1994. CD40 expression in malignant plasma cells: role in stimulation of autocrine IL-6 secretion in a human myeloma cell line. J. Immunol. 152:117.
5. Muraguchi, A., T. Hirano, B. Tang, T. Matsuda, Y. Horii, K. Nakajima, and T. Kishimoto. 1988. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167:332.
6. Splawski, J. B., L. M. McAnally, and P. E. Lipsky. 1990. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2). J Immunol. 114:562.
7. Kishimoto, T., S. Akira, M. Narazaki, and T. Taga. 1995. Interleukin-6 family of cytokines and gp130. Blood 86:243.
8. Rose, T. M., and A. G. Bruce. 1991. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc. Natl. Acad. Sci. USA 88:8641.
9. Hibi, M., M. Murakami, M. Saito, T. Hirano, T. Taga, and T. Kishimoto. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149.
10. Gearing, D. P., M. R. Comeau, D. J. Friend, S. D. Gimpel, C. J. Thut, J. McGourty, K. K. Brasher, J. A. King, S. Gillis, B. Mosley, S. F. Ziegler, and D. Cosman. 1992. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434.
11. Gearing, D. P., C. J. Thut, T. VandenBos, S. D. Gimpel, P. B. Delaney, J. King, V. Price, D. Cosman, and M. P. Beckmann. 1991. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 10:2839.
12. Zarling, J. M., M. Shoyab, H. Maruquardt, M. B. Hanson, M. N. Lioubin, and G. J. Todaro. 1986. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA 83:9739.
13. Nair, B. C., A. L. DeVico, S. Nakamura, T. D. Copeland, Y. Chen, A. Patel, T. O'Neil, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1992. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 255:1430.
14. Miles, D. A., O. Martinez-Maga, A. Rezai, L. Magpantay, T. Kishimoto, S. Nakamura, S. F. Radka, and P. S. Linsley. 1992. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255:1432.
15. Cai, J., P. S. Gill, R. Masood, P. Chandrasoma, B. Jung, R. E. Law, and S. F. Radka. 1994. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am. J. Pathol. 145:74.
16. Mosley, B., C. Delmus, D. Friend, B. Thoma, and D. Cosman. 1994. The oncostatin-M specific receptor: cloning of a novel subunit related to the LIF receptor. Cytokine 6:554.
17. Taga, T., M. Narazaki, K. Yasukawa, T. Saito, D. Miki, M. Hamaguchi, S. Davis, M. Shoyab, G. D. Yancopoulos, and T. Kishimoto. 1992. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 89:10998.
18. Zhang, X. G., J. J. Gu, Z. Y. Lu, K. Yasukawa, G. D. Yancopoulos, K. Turner, M. Shoyab, T. Taga, T. Kishimoto, R. Bataille, and B. Klein. 1994. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med. 177:1337.
19. Nishimoto, N., A. Ogata, Y. Shima, Y. Tani, H. Ogawa, M. Nakagawa, H. Sugiyama, K. Yoshizaki, and T. Kishimoto. 1994. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J. Exp. Med. 179:1343.
20. Westendorf, J. J., G. J. Ahmann, P. R. Greipp, T. E. Witzig, R. A. Kyle, J. A. Lust, and D. F. Jelinek. 1996. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia 10:866.
21. Paul, S. R., F. Bennett, J. A. Calvetti, K. Kelleher, C. R. Wood, R. M. O'Hara, Jr., A. C. Leary, B. Sibley, S. C. Clark, D. A. Williams, and Y. C. Yang. 1990. Molecular cloning of a cDNA encoding interletkin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87:7512.
22. Hirohata, S., D. F. Jelinek, and P. E. Lipsky. 1988. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J. Immunol. 40:3726.
23. Thiele, D. L., and P. E. Lipsky. 1983. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in the human peripheral blood: delineation by its sensitivity to the lysosomotropic agent L-leucine methyl ester. J. Immunol. 131:2282.
24. Galili, U., and M. Schlesinger. 1974. The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. J. Immunol 112:1628.
25. Jelinek, D. F., and P. E. Lipsky. 1985. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells. J. Immunol. 134:1690.
26. Amoroso, K., and P. E. Lipsky. 1990. Frequency of human B cells that differentiate in response to anti-CD3-activated T cell. J. Immunol. 145:3155.
27. Vernino L., L. M. McAnally, J. Ramberg, and P. E. Lipsky. 1992. Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells. J. Immunol 148:404.
28. Jelinek, D. F., J. B. Splawski, and P. E. Lipsky. 1986. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets. J. Immunol. 136:83.
29. Jernberg-Wiklund H., M. Pettersson, A. Carlsson, and K. Nilsson. 1992. Increase in interleukin (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. Leukemia 6:310.
30. Jelinek, D. F., and P. E. Lipsky. 1983. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man. J. Immunol. 130:2597.
31. Jelinek, D. F., J. B. Splawski, and P. E. Lipsky: 1986. The roles of interleukin 2 and IFN-γ in human B cell activation, growth, and differentiation. Eur. J. Immunol. 16:925.
32. Hutchins, D., B. B. Cohen, and C. M. Steel. 1990. Production and regulation of interleukin 6 in human B lymphoid cells. Eur. J. Immunol. 20:961.
33. 1 mRNAs. J. Exp. Med. 178:521.
34. 1. Eur. J. Immunol. 25:508.
35. Tamura, T., N. Udagawa, N. Takahashi, C. Miyaura, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K. Kumaki, T. Taga, T. Kishimoto, and T. Suda. 1993. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. USA 90:11924.
36. Richards, C. D., and A. Agro. 1994. Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblasts. Cytokine 6:40.
37. Brown, J. T., J. M. Rowe, J. Liu, and M. Shoyab. 1991. Regulation of IL-6 expression by oncostatin M. J. Immunol. 147:2175.
38. Juge-Morineau, N., S. Francois, D. Puthier, A. Godard, R. Bataille, and M. Amiot. 1995. The gp130 family of cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells. Br. J. Haematol. 90:707.
39. Anderson, K. C., C. Morimoto, S. R. Paul, D. Chaudan, D. Williams, M. Cochran, and B. A. Barut. 1992. Interleukin-11 promotes accessory cell-dependent B cell differentiation in humans. Blood 80:2797.